The global extended release drugs market is experiencing significant growth, projected to expand at a robust 11% CAGR from 2022 to 2032. With a valuation of USD 48 billion in 2022, the market is ...

We recently published a list of the 10 Best Strong Buy Stocks To Buy Right Now. In this article, we are going to take a look at where Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) ...

Newbury Pharmaceuticals is pleased to announce the successful Marketing Authorization (MA) of Macitentan Newbury in Denmark as the first country in a Scandinavian registration procedure. Approvals in ...

Nordea is off to a strong 2025, returning over 30%. Learn why NRDBY stock remains attractive even with expected earnings ...

MilDef Group AB posted the largest decline among large stocks during the session, declining 6.9%, followed by Clas Ohlson AB Series B shares, which fell 6.8%. Shares of Tomra Systems ASA dropped 5.5%.

Headquartered in Denmark, LEO Pharma has a team of 4,000 people worldwide. LEO Pharma is co-owned by majority shareholder the LEO Foundation and, since 2021, Nordic Capital. For more information, ...

The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.

In the years to come, Bavarian Nordic foresees that more commercially minded-business taking the lead over the sort of ...

The European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine approved in Europe for individuals as young as 12 years old. Vimkunya is a virus ...

Credit: Pormezz/Shutterstock. The European Commission (EC) has authorised the marketing of Bavarian Nordic’s Vimkunya – the first chikungunya vaccine approved in Europe for individuals as young as 12 ...